Search

Your search keyword '"Kouwenhoven, E A"' showing total 222 results
Start Over Author "Kouwenhoven, E A"
222 results on '"Kouwenhoven, E A"'

4. Staging laparoscopy in gastric cancer patients:From a Dutch nationwide Delphi consensus towards a standardized protocol

Author

van der Sluis, Karen, Guchelaar, Niels A.D., Triemstra, Lianne, Mathijssen, Ron H.J., Ruurda, Jelle P., Wijnhoven, Bas P.L., van Sandick, Johanna W., Daams, F., van der Sluis, P. C., Lagarde, S. M., Noordman, B. J., Heisterkamp, J., Matthée, E. P.C., Wassenaar, E. B., Pierik, E. G.J.M., van der Harst, E., Veenhof, A. A.F.A., van Etten, B., van Hillegersberg, R., van den Berg, J. W., Brenkman, H. J.F., Kouwenhoven, E. A., van der Sluis, Karen, Guchelaar, Niels A.D., Triemstra, Lianne, Mathijssen, Ron H.J., Ruurda, Jelle P., Wijnhoven, Bas P.L., van Sandick, Johanna W., Daams, F., van der Sluis, P. C., Lagarde, S. M., Noordman, B. J., Heisterkamp, J., Matthée, E. P.C., Wassenaar, E. B., Pierik, E. G.J.M., van der Harst, E., Veenhof, A. A.F.A., van Etten, B., van Hillegersberg, R., van den Berg, J. W., Brenkman, H. J.F., and Kouwenhoven, E. A.

Abstract

Background: Staging laparoscopy is a common diagnostic tool in gastric cancer, but its performance varies widely. The aim of this study was to gain Dutch nationwide consensus regarding the indications for and execution of staging laparoscopy in patients with gastric cancer. Methods: All surgeons in the Netherlands specialized in gastric cancer surgery (n = 52) were asked to participate in a Delphi consensus study. The study involved an initial questionnaire with a 3-point Likert scale, an online consensus meeting, and a second questionnaire using a 2-point Likert scale (agree/disagree). Consensus was defined as 70% or more agreement among participants. Results: In total, 45 experts completed both questionnaires (87% response rate). Consensus was reached on the indication to perform staging laparoscopy in cT3-4 or cN + or diffuse-type gastric cancer, including Siewert type III oesophagogastric junctional cancer. The experts agreed that if preoperative scans suggest infiltration of surrounding organs (cT4), the tumour's resectability should explicitly be investigated. Consensus was also reached for a systematic peritoneal cavity inspection according to Sugarbaker's Peritoneal Cancer Index (PCI) score. All regions should be inspected routinely, although the omental bursa may be inspected on indication. Aspiration of ascites or peritoneal washing should be performed for cytology. The experts agreed that restaging laparoscopy should be performed before resection in case of progressive disease on preoperative imaging. Without progression, global inspection was considered sufficient. Conclusions: The results of this Dutch nationwide Delphi consensus study exposed the variability of performing staging laparoscopy in patients with gastric cancer and provided the concept for a standardized protocol.

Published
2024

7. Training curriculum in minimally invasive emergency digestive surgery: 2022 WSES position paper

Author

De'Angelis, N, Marchegiani, F, Schena, C, Khan, J, Agnoletti, V, Ansaloni, L, Barria Rodriguez, A, Bianchi, P, Biffl, W, Bravi, F, Ceccarelli, G, Ceresoli, M, Chiara, O, Chirica, M, Cobianchi, L, Coccolini, F, Coimbra, R, Cotsoglou, C, D'Hondt, M, Damaskos, D, De Simone, B, Di Saverio, S, Diana, M, Espin-Basany, E, Fichtner-Feigl, S, Fugazzola, P, Gavriilidis, P, Gronnier, C, Kashuk, J, Kirkpatrick, A, Ammendola, M, Kouwenhoven, E, Laurent, A, Leppaniemi, A, Lesurtel, M, Memeo, R, Milone, M, Moore, E, Pararas, N, Peitzmann, A, Pessaux, P, Picetti, E, Pikoulis, M, Pisano, M, Ris, F, Robison, T, Sartelli, M, Shelat, V, Spinoglio, G, Sugrue, M, Tan, E, Van Eetvelde, E, Kluger, Y, Weber, D, Catena, F, de'Angelis N., Marchegiani F., Schena C. A., Khan J., Agnoletti V., Ansaloni L., Barria Rodriguez A. G., Bianchi P. P., Biffl W., Bravi F., Ceccarelli G., Ceresoli M., Chiara O., Chirica M., Cobianchi L., Coccolini F., Coimbra R., Cotsoglou C., D'Hondt M., Damaskos D., De Simone B., Di Saverio S., Diana M., Espin-Basany E., Fichtner-Feigl S., Fugazzola P., Gavriilidis P., Gronnier C., Kashuk J., Kirkpatrick A. W., Ammendola M., Kouwenhoven E. A., Laurent A., Leppaniemi A., Lesurtel M., Memeo R., Milone M., Moore E., Pararas N., Peitzmann A., Pessaux P., Picetti E., Pikoulis M., Pisano M., Ris F., Robison T., Sartelli M., Shelat V. G., Spinoglio G., Sugrue M., Tan E., Van Eetvelde E., Kluger Y., Weber D., Catena F., De'Angelis, N, Marchegiani, F, Schena, C, Khan, J, Agnoletti, V, Ansaloni, L, Barria Rodriguez, A, Bianchi, P, Biffl, W, Bravi, F, Ceccarelli, G, Ceresoli, M, Chiara, O, Chirica, M, Cobianchi, L, Coccolini, F, Coimbra, R, Cotsoglou, C, D'Hondt, M, Damaskos, D, De Simone, B, Di Saverio, S, Diana, M, Espin-Basany, E, Fichtner-Feigl, S, Fugazzola, P, Gavriilidis, P, Gronnier, C, Kashuk, J, Kirkpatrick, A, Ammendola, M, Kouwenhoven, E, Laurent, A, Leppaniemi, A, Lesurtel, M, Memeo, R, Milone, M, Moore, E, Pararas, N, Peitzmann, A, Pessaux, P, Picetti, E, Pikoulis, M, Pisano, M, Ris, F, Robison, T, Sartelli, M, Shelat, V, Spinoglio, G, Sugrue, M, Tan, E, Van Eetvelde, E, Kluger, Y, Weber, D, Catena, F, de'Angelis N., Marchegiani F., Schena C. A., Khan J., Agnoletti V., Ansaloni L., Barria Rodriguez A. G., Bianchi P. P., Biffl W., Bravi F., Ceccarelli G., Ceresoli M., Chiara O., Chirica M., Cobianchi L., Coccolini F., Coimbra R., Cotsoglou C., D'Hondt M., Damaskos D., De Simone B., Di Saverio S., Diana M., Espin-Basany E., Fichtner-Feigl S., Fugazzola P., Gavriilidis P., Gronnier C., Kashuk J., Kirkpatrick A. W., Ammendola M., Kouwenhoven E. A., Laurent A., Leppaniemi A., Lesurtel M., Memeo R., Milone M., Moore E., Pararas N., Peitzmann A., Pessaux P., Picetti E., Pikoulis M., Pisano M., Ris F., Robison T., Sartelli M., Shelat V. G., Spinoglio G., Sugrue M., Tan E., Van Eetvelde E., Kluger Y., Weber D., and Catena F.

Abstract

Background: Minimally invasive surgery (MIS), including laparoscopic and robotic approaches, is widely adopted in elective digestive surgery, but selectively used for surgical emergencies. The present position paper summarizes the available evidence concerning the learning curve to achieve proficiency in emergency MIS and provides five expert opinion statements, which may form the basis for developing standardized curricula and training programs in emergency MIS. Methods: This position paper was conducted according to the World Society of Emergency Surgery methodology. A steering committee and an international expert panel were involved in the critical appraisal of the literature and the development of the consensus statements. Results: Thirteen studies regarding the learning curve in emergency MIS were selected. All but one study considered laparoscopic appendectomy. Only one study reported on emergency robotic surgery. In most of the studies, proficiency was achieved after an average of 30 procedures (range: 20–107) depending on the initial surgeon’s experience. High heterogeneity was noted in the way the learning curve was assessed. The experts claim that further studies investigating learning curve processes in emergency MIS are needed. The emergency surgeon curriculum should include a progressive and adequate training based on simulation, supervised clinical practice (proctoring), and surgical fellowships. The results should be evaluated by adopting a credentialing system to ensure quality standards. Surgical proficiency should be maintained with a minimum caseload and constantly evaluated. Moreover, the training process should involve the entire surgical team to facilitate the surgeon’s proficiency. Conclusions: Limited evidence exists concerning the learning process in laparoscopic and robotic emergency surgery. The proposed statements should be seen as a preliminary guide for the surgical community while stressing the need for further research.

Published
2023

11. Paravertebral catheter versus EPidural analgesia in Minimally invasive Esophageal resectioN: a randomized controlled multicenter trial (PEPMEN trial)

Author

Kingma, B. F., Eshuis, W. J., de Groot, E. M., Feenstra, M. L., Ruurda, J. P., Gisbertz, S. S., ten Hoope, W., Marsman, M., Hermanides, J., Hollmann, M. W., Kalkman, C. J., Luyer, M. D. P., Nieuwenhuijzen, G. A. P., Scholten, H. J., Buise, M., van Det, M. J., Kouwenhoven, E. A., van der Meer, F., Frederix, G. W. J., Cheong, E., al Naimi, K., van Berge Henegouwen, M. I., and van Hillegersberg, R.

Published
2020
Full Text
View/download PDF

12. Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: a multicenter prospective study (PLASTIC-study)

Author

Brenkman, H. J. F., Gertsen, E. C., Vegt, E., van Hillegersberg, R., van Berge Henegouwen, M. I., Gisbertz, S. S., Luyer, M. D. P., Nieuwenhuijzen, G. A. P., van Lanschot, J. J. B., Lagarde, S. M., de Steur, W. O., Hartgrink, H. H., Stoot, J. H. M. B., Hulsewe, K. W. E., Spillenaar Bilgen, E. J., van Det, M. J., Kouwenhoven, E. A., van der Peet, D. L., Daams, F., van Sandick, J. W., van Grieken, N. C. T., Heisterkamp, J., van Etten, B., Haveman, J. W., Pierie, J. P., Jonker, F., Thijssen, A. Y., Belt, E. J. T., van Duijvendijk, P., Wassenaar, E., van Laarhoven, H. W. M., Wessels, F. J., Haj Mohammad, N., van Stel, H. F., Frederix, G. W. J., Siersema, P. D., Ruurda, J. P., and on behalf of the PLASTIC Study Group

Published
2018
Full Text
View/download PDF

13. Clinical variation in the organization of clinical pathways in esophagogastric cancer, a mixed method multiple case study

Author

MS Medische Oncologie, Cancer, Luijten, J C H B M, Vissers, P A J, Brom, L, de Bièvre, M, Buijsen, J, Rozema, T, Mohammad, N Haj, van Duijvendijk, P, Kouwenhoven, E A, Eshuis, W J, Rosman, C, Siersema, P D, van Laarhoven, H W M, Verhoeven, R H A, Nieuwenhuijzen, G A P, Westerman, M J, MS Medische Oncologie, Cancer, Luijten, J C H B M, Vissers, P A J, Brom, L, de Bièvre, M, Buijsen, J, Rozema, T, Mohammad, N Haj, van Duijvendijk, P, Kouwenhoven, E A, Eshuis, W J, Rosman, C, Siersema, P D, van Laarhoven, H W M, Verhoeven, R H A, Nieuwenhuijzen, G A P, and Westerman, M J

Published
2022

14. 10: INTRATHORACIC VERSUS CERVICAL ANASTOMOSIS AFTER MINIMALLY INVASIVE OESOPHAGECTOMY FOR OESOPHAGEAL CANCER: A RANDOMISED CONTROLLED TRIAL

Author

Van Workum, F, primary, Verstegen, M, additional, Klarenbeek, B, additional, Bouwense, S, additional, Van Berge Henegouwen, M, additional, Daams, F, additional, Gisbertz, S, additional, Hannink, G, additional, Haveman, J W, additional, Heisterkamp, J, additional, Jansen, W, additional, Kouwenhoven, E, additional, Van Lanschot, J, additional, Nieuwenhuijzen, G, additional, Van Der Peet, D, additional, Polat, F, additional, Ubels, S, additional, Wijnhoven, B, additional, Rovers, M, additional, and Rosman, C, additional

Published
2022
Full Text
View/download PDF

15. Additional file 1 of Clinical variation in the organization of clinical pathways in esophagogastric cancer, a mixed method multiple case study

Author

Luijten, J. C. H. B. M., Vissers, P. A. J., Brom, L., de Bièvre, M., Buijsen, J., Rozema, T., Mohammad, N. Haj, van Duijvendijk, P., Kouwenhoven, E. A., Eshuis, W. J., Rosman, C., Siersema, P. D., van Laarhoven, H. W. M., Verhoeven, R. H. A., Nieuwenhuijzen, G. A. P., and Westerman, M. J.

Subjects
Data_FILES
Abstract

Additional file 1.

Published
2022
Full Text
View/download PDF

19. Prognostic value of patient-reported quality of life for survival in oesophagogastric cancer: Analysis from the population-based POCOP study

Author

Dutch Upper GI Canc Grp DUCG, van Kleef, J. J., Dijksterhuis, W. P. M., van den Boorn, H. G., Prins, M., Verhoeven, R. H. A., Gisbertz, S. S., Slingerland, M., Mohammad, N. Haj, Creemers, G-J, Neelis, K. J., Heisterkamp, J., Rosman, C., Ruurda, J. P., Kouwenhoven, E. A., van de Poll-Franse, L. V., van Oijen, M. G. H., Sprangers, M. A. G., van Laarhoven, H. W. M., Dutch Upper GI Canc Grp DUCG, van Kleef, J. J., Dijksterhuis, W. P. M., van den Boorn, H. G., Prins, M., Verhoeven, R. H. A., Gisbertz, S. S., Slingerland, M., Mohammad, N. Haj, Creemers, G-J, Neelis, K. J., Heisterkamp, J., Rosman, C., Ruurda, J. P., Kouwenhoven, E. A., van de Poll-Franse, L. V., van Oijen, M. G. H., Sprangers, M. A. G., and van Laarhoven, H. W. M.

Abstract

Background Accumulating evidence of trials demonstrates that patient-reported health-related quality of life (HRQoL) at diagnosis is prognostic for overall survival (OS) in oesophagogastric cancer. However, real-world data are lacking. Moreover, differences in disease stages and tumour-specific symptoms are usually not taken into consideration. The aim of this population-based study was to assess the prognostic value of HRQoL, including tumour-specific scales, on OS in patients with potentially curable and advanced oesophagogastric cancer. Methods Data were derived from the Netherlands Cancer Registry and the patient reported outcome registry (POCOP). Patients included in POCOP between 2016 and 2018 were stratified for potentially curable (cT1-4aNallM0) or advanced (cT4b or cM1) disease. HRQoL was measured with the EORTC QLQ-C30 and the tumour-specific OG25 module. Cox proportional hazards models assessed the impact of HRQoL, sociodemographic and clinical factors (including treatment) on OS. Results In total, 924 patients were included. Median OS was 38.9 months in potentially curable patients (n = 795) and 10.6 months in patients with advanced disease (n = 129). Global Health Status was independently associated with OS in potentially curable patients (HR 0.89, 99%CI 0.82-0.97), together with several other HRQoL items: appetite loss, dysphagia, eating restrictions, odynophagia, and body image. In advanced disease, the Summary Score was the strongest independent prognostic factor (HR 0.75, 99%CI 0.59-0.94), followed by fatigue, pain, insomnia and role functioning. Conclusion In a real-world setting, HRQoL was prognostic for OS in patients with potentially curable and advanced oesophagogastric cancer. Several HRQoL domains, including the Summary Score and several OG25 items, could be used to develop or update prognostic models.

Published
2021

20. Supervised exercise after oesophageal cancer surgery:the PERFECT multicentre randomized clinical trial

Author

van Vulpen, J. K., Hiensch, A. E., van Hillegersberg, R., Ruurda, J. P., Backx, F. J.G., Nieuwenhuijzen, G. A.P., Kouwenhoven, E. A., Groenendijk, R. P.R., van der Peet, D. L., Hazebroek, E. J., Rosman, C., Wijnhoven, B. P.L., van Berge Henegouwen, M. I., van Laarhoven, H. W.M., Siersema, P. D., May, A. M., van Vulpen, J. K., Hiensch, A. E., van Hillegersberg, R., Ruurda, J. P., Backx, F. J.G., Nieuwenhuijzen, G. A.P., Kouwenhoven, E. A., Groenendijk, R. P.R., van der Peet, D. L., Hazebroek, E. J., Rosman, C., Wijnhoven, B. P.L., van Berge Henegouwen, M. I., van Laarhoven, H. W.M., Siersema, P. D., and May, A. M.

Abstract

BACKGROUND: This study investigated whether a supervised exercise programme improves quality of life (QoL), fatigue and cardiorespiratory fitness in patients in the first year after oesophagectomy. METHODS: The multicentre PERFECT trial randomly assigned patients to an exercise intervention (EX) or usual care (UC) group. EX patients participated in a 12-week moderate- to high-intensity aerobic and resistance exercise programme supervised by a physiotherapist. Primary (global QoL, QoL summary score) and secondary (QoL subscales, fatigue and cardiorespiratory fitness) outcomes were assessed at baseline, 12 and 24 weeks and analysed as between-group differences using either linear mixed effects models or ANCOVA. RESULTS: A total of 120 patients (mean(s.d.) age 64(8) years) were included and randomized to EX (61 patients) or UC (59 patients). Patients in the EX group participated in 96 per cent (i.q.r. 92-100 per cent) of the exercise sessions and the relative exercise dose intensity was high (92 per cent). At 12 weeks, beneficial EX effects were found for QoL summary score (3.5, 95 per cent c.i. 0.2 to 6.8) and QoL role functioning (9.4, 95 per cent c.i. 1.3 to 17.5). Global QoL was not statistically significant different between groups (3.0, 95 per cent c.i. -2.2 to 8.2). Physical fatigue was lower in the EX group (-1.2, 95 per cent c.i. -2.6 to 0.1), albeit not significantly. There was statistically significant improvement in cardiorespiratory fitness following EX compared with UC (peak oxygen uptake (1.8 ml/min/kg, 95 per cent c.i. 0.6 to 3.0)). After 24 weeks, all EX effects were attenuated. CONCLUSIONS: A supervised exercise programme improved cardiorespiratory fitness and aspects of QoL. TRIAL REGISTRATION: Dutch Trial Register NTR 5045 (www.trialregister.nl/trial/4942).

Published
2021

21. Supervised exercise after oesophageal cancer surgery: the PERFECT multicentre randomized clinical trial

Author

Arts-assistenten Radiotherapie, JC onderzoeksprogramma Kanker, Epi Kanker Team B, Cancer, MS CGO, RF&S Team 2 Medisch, Brain, Epidemiology & Health Economics, van Vulpen, J K, Hiensch, A E, van Hillegersberg, R, Ruurda, J P, Backx, F J G, Nieuwenhuijzen, G A P, Kouwenhoven, E A, Groenendijk, R P R, van der Peet, D L, Hazebroek, E J, Rosman, C, Wijnhoven, B P L, van Berge Henegouwen, Mark I, van Laarhoven, H W M, Siersema, PD, May, A M, Arts-assistenten Radiotherapie, JC onderzoeksprogramma Kanker, Epi Kanker Team B, Cancer, MS CGO, RF&S Team 2 Medisch, Brain, Epidemiology & Health Economics, van Vulpen, J K, Hiensch, A E, van Hillegersberg, R, Ruurda, J P, Backx, F J G, Nieuwenhuijzen, G A P, Kouwenhoven, E A, Groenendijk, R P R, van der Peet, D L, Hazebroek, E J, Rosman, C, Wijnhoven, B P L, van Berge Henegouwen, Mark I, van Laarhoven, H W M, Siersema, PD, and May, A M

Published
2021

22. LBA75 Neoadjuvant chemoradiotherapy followed by surgery versus active surveillance for oesophageal cancer (SANO-trial): A phase-III stepped-wedge cluster randomised trial

Author

van der Wilk, B.J., Eyck, B.M., Wijnhoven, B.P.L., Lagarde, S.M., Rosman, C., Noordman, B.J., Valkema, M.J., Coene, P-P., Dekker, J-W., Hartgrink, H., Heisterkamp, J., Kouwenhoven, E., Nieuwenhuijzen, G., Pierie, J-P., van Sandick, J., Sosef, M., Spaander, M., van der Zaag, E., Steyerberg, E., and van Lanschot, J.

Published
2023
Full Text
View/download PDF

23. Supervised exercise after oesophageal cancer surgery: the PERFECT multicentre randomized clinical trial

Author

van Vulpen, J K, primary, Hiensch, A E, additional, van Hillegersberg, R, additional, Ruurda, J P, additional, Backx, F J G, additional, Nieuwenhuijzen, G A P, additional, Kouwenhoven, E A, additional, Groenendijk, R P R, additional, van der Peet, D L, additional, Hazebroek, E J, additional, Rosman, C, additional, Wijnhoven, B P L, additional, van Berge Henegouwen, M I, additional, van Laarhoven, H W M, additional, Siersema, P D, additional, and May, A M, additional

Published
2021
Full Text
View/download PDF

24. Resection of hepatic and pulmonary metastasis from metastatic esophageal and gastric cancer

Author

Seesing, M F J, van der Veen, A, Brenkman, H J F, Stockmann, H B A C, Nieuwenhuijzen, G A P, Rosman, C, van den Wildenberg, F J H, van Berge Henegouwen, Mark I, van Duijvendijk, P, Wijnhoven, B P L, Stoot, J H M B, Lacle, M, Ruurda, J P, van Hillegersberg, R, Baas, P C, Boerma, D, de Steur, W O, de Waard, J W D, Heisterkamp, J, van Hillo, M, Kouwenhoven, E A, Liem, M S L, van der Peet, D L, Pierie, J P E N, Plukker, J T M, Roumen, R M H, Tetteroo, G W M, van Workum, F, CCA - Cancer Treatment and Quality of Life, AGEM - Re-generation and cancer of the digestive system, Surgery, Lifelong Learning, Education & Assessment Research Network (LEARN), Damage and Repair in Cancer Development and Cancer Treatment (DARE), and Guided Treatment in Optimal Selected Cancer Patients (GUTS)

Subjects
Male, Lung Neoplasms, Esophageal Neoplasms, SURGERY, medicine.medical_treatment, Kaplan-Meier Estimate, RADICAL ESOPHAGECTOMY, Gastroenterology, Metastasis, COLORECTAL-CANCER, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], hepatic surgery, 0302 clinical medicine, Pulmonary metastasis, Medicine, Registries, Prospective cohort study, Neoadjuvant therapy, Netherlands, Liver Neoplasms, SURGICAL RESECTION, esophageal and gastric cancer, General Medicine, CHEMOTHERAPY, Middle Aged, Combined Modality Therapy, Survival Rate, Treatment Outcome, Esophagectomy, 030220 oncology & carcinogenesis, 030211 gastroenterology & hepatology, Original Article, Female, Metastasectomy, pulmonary surgery, Erratum, medicine.medical_specialty, CARCINOMA, RECURRENCE PATTERN, Resection, LIVER METASTASES, CHEMORADIOTHERAPY, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Gastrectomy, Stomach Neoplasms, Internal medicine, Carcinoma, metastasis, Humans, Aged, esophageal and gastric surgery, business.industry, Neuroendocrine neoplasm, Cancer, LONG-TERM SURVIVAL, medicine.disease, Surgery, business, Author name, Chemoradiotherapy
Abstract

SUMMARY The standard of care for gastroesophageal cancer patients with hepatic or pulmonary metastases is best supportive care or palliative chemotherapy. Occasionally, patients can be selected for curative treatment instead. This study aimed to evaluate patients who underwent a resection of hepatic or pulmonary metastasis with curative intent. The Dutch national registry for histo- and cytopathology was used to identify these patients. Data were retrieved from the individual patient files. Kaplan–Meier survival analysis was performed. Between 1991 and 2016, 32,057 patients received a gastrectomy or esophagectomy for gastroesophageal cancer in the Netherlands. Of these patients, 34 selected patients received a resection of hepatic metastasis (n = 19) or pulmonary metastasis (n = 15) in 21 different hospitals. Only 4 patients received neoadjuvant therapy before metastasectomy. The majority of patients had solitary, metachronous metastases. After metastasectomy, grade 3 (Clavien–Dindo) complications occurred in 7 patients and mortality in 1 patient. After resection of hepatic metastases, the median potential follow-up time was 54 months. Median overall survival (OS) was 28 months and the 1-, 3-, and 5- year OS was 84%, 41%, and 31%, respectively. After pulmonary metastases resection, the median potential follow-up time was 80 months. The median OS was not reached and the 1-, 3-, and 5- year OS was 67%, 53%, and 53%, respectively. In selected patients with gastroesophageal cancer with hepatic or pulmonary metastases, metastasectomy was performed with limited morbidity and mortality and offered a 5-year OS of 31–53%. Further prospective studies are required.

Published
2020

25. Paravertebral catheter versus EPidural analgesia in Minimally invasive Esophageal resectioN : a randomized controlled multicenter trial (PEPMEN trial)

Author

Kingma, B F, Eshuis, W J, de Groot, E M, Feenstra, M L, Ruurda, J P, Gisbertz, S S, Ten Hoope, W, Marsman, M, Hermanides, J, Hollmann, M W, Kalkman, C J, Luyer, M D P, Nieuwenhuijzen, G A P, Scholten, H J, Buise, M, van Det, M J, Kouwenhoven, E A, van der Meer, F, Frederix, G W J, Cheong, E, Al Naimi, K, van Berge Henegouwen, M I, van Hillegersberg, R, Kingma, B F, Eshuis, W J, de Groot, E M, Feenstra, M L, Ruurda, J P, Gisbertz, S S, Ten Hoope, W, Marsman, M, Hermanides, J, Hollmann, M W, Kalkman, C J, Luyer, M D P, Nieuwenhuijzen, G A P, Scholten, H J, Buise, M, van Det, M J, Kouwenhoven, E A, van der Meer, F, Frederix, G W J, Cheong, E, Al Naimi, K, van Berge Henegouwen, M I, and van Hillegersberg, R

Published
2020

26. Paravertebral catheter versus EPidural analgesia in Minimally invasive Esophageal resectioN: a randomized controlled multicenter trial (PEPMEN trial)

Author

MS CGO, Cancer, Medische staf Anesthesiologie, Other research (not in main researchprogram), Brain, Circulatory Health, HEE, Child Health, JC onderzoeksprogramma Methodologie, Divisie Beeld & Oncologie, Kingma, B F, Eshuis, W J, de Groot, E M, Feenstra, M L, Ruurda, J P, Gisbertz, S S, Ten Hoope, W, Marsman, M, Hermanides, J, Hollmann, M W, Kalkman, C J, Luyer, M D P, Nieuwenhuijzen, G A P, Scholten, H J, Buise, M, van Det, M J, Kouwenhoven, E A, van der Meer, F, Frederix, G W J, Cheong, E, Al Naimi, K, van Berge Henegouwen, M I, van Hillegersberg, R, MS CGO, Cancer, Medische staf Anesthesiologie, Other research (not in main researchprogram), Brain, Circulatory Health, HEE, Child Health, JC onderzoeksprogramma Methodologie, Divisie Beeld & Oncologie, Kingma, B F, Eshuis, W J, de Groot, E M, Feenstra, M L, Ruurda, J P, Gisbertz, S S, Ten Hoope, W, Marsman, M, Hermanides, J, Hollmann, M W, Kalkman, C J, Luyer, M D P, Nieuwenhuijzen, G A P, Scholten, H J, Buise, M, van Det, M J, Kouwenhoven, E A, van der Meer, F, Frederix, G W J, Cheong, E, Al Naimi, K, van Berge Henegouwen, M I, and van Hillegersberg, R

Published
2020

34. European consensus on essential steps of Minimally Invasive Ivor Lewis and McKeown Esophagectomy through Delphi methodology.

Author

Eddahchouri, Yassin, van Workum, Frans, van den Wildenberg, Frits J. H., van Berge Henegouwen, Mark I., Polat, Fatih, van Goor, Harry, MIE Delphi Collaboration, Chaudry, M. Asif, Cheong, E., Daams, F., van Det, M. J., Gutschow, C., Heisterkamp, J., Van Hillegersberg, R., Hölscher, A., Kouwenhoven, E. A., Luyer, M. D. P., Martijnse, I. S., Nafteux, P., and Nieuwenhuijzen, G. A. P.

Subjects
ESOPHAGECTOMY, CRONBACH'S alpha, MINIMALLY invasive procedures
Abstract

Background: Minimally invasive esophagectomy (MIE) is a complex and technically demanding procedure with a long learning curve, which is associated with increased morbidity and mortality. To master MIE, training in essential steps is crucial. Yet, no consensus on essential steps of MIE is available. The aim of this study was to achieve expert consensus on essential steps in Ivor Lewis and McKeown MIE through Delphi methodology. Methods: Based on expert opinion and peer-reviewed literature, essential steps were defined for Ivor Lewis (IL) and McKeown (McK) MIE. In a round table discussion, experts finalized the lists of steps and an online Delphi questionnaire was sent to an international expert panel (7 European countries) of minimally invasive upper GI surgeons. Based on replies and comments, steps were adjusted and rephrased and sent in iterative fashion until consensus was achieved. Results: Two Delphi rounds were conducted and response rates were 74% (23 out of 31 experts) for the first and 81% (27 out of 33 experts) for the second round. Consensus was achieved on 106 essential steps for both the IL and McK approach. Cronbach's alpha in the first round was 0.78 (IL) and 0.78 (McK) and in the second round 0.92 (IL) and 0.88 (McK). Conclusions: Consensus among European experts was achieved on essential surgical steps for both Ivor Lewis and McKeown minimally invasive esophagectomy. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

35. Prognostic value of patient-reported quality of life for survival in oesophagogastric cancer: analysis from the population-based POCOP study.

Author

van Kleef, J. J., Dijksterhuis, W. P. M., van den Boorn, H. G., Prins, M., Verhoeven, R. H. A., Gisbertz, S. S., Slingerland, M., Mohammad, N. Haj, Creemers, G.-J., Neelis, K. J., Heisterkamp, J., Rosman, C., Ruurda, J. P., Kouwenhoven, E. A., van de Poll-Franse, L. V., van Oijen, M. G. H., Sprangers, M. A. G., and van Laarhoven, H. W. M.

Subjects
QUALITY of life, PROGNOSIS, OVERALL survival, PROPORTIONAL hazards models, PROGNOSTIC models
Abstract

Background: Accumulating evidence of trials demonstrates that patient-reported health-related quality of life (HRQoL) at diagnosis is prognostic for overall survival (OS) in oesophagogastric cancer. However, real-world data are lacking. Moreover, differences in disease stages and tumour-specific symptoms are usually not taken into consideration. The aim of this population-based study was to assess the prognostic value of HRQoL, including tumour-specific scales, on OS in patients with potentially curable and advanced oesophagogastric cancer. Methods: Data were derived from the Netherlands Cancer Registry and the patient reported outcome registry (POCOP). Patients included in POCOP between 2016 and 2018 were stratified for potentially curable (cT1-4aNallM0) or advanced (cT4b or cM1) disease. HRQoL was measured with the EORTC QLQ-C30 and the tumour-specific OG25 module. Cox proportional hazards models assessed the impact of HRQoL, sociodemographic and clinical factors (including treatment) on OS. Results: In total, 924 patients were included. Median OS was 38.9 months in potentially curable patients (n = 795) and 10.6 months in patients with advanced disease (n = 129). Global Health Status was independently associated with OS in potentially curable patients (HR 0.89, 99%CI 0.82–0.97), together with several other HRQoL items: appetite loss, dysphagia, eating restrictions, odynophagia, and body image. In advanced disease, the Summary Score was the strongest independent prognostic factor (HR 0.75, 99%CI 0.59–0.94), followed by fatigue, pain, insomnia and role functioning. Conclusion: In a real-world setting, HRQoL was prognostic for OS in patients with potentially curable and advanced oesophagogastric cancer. Several HRQoL domains, including the Summary Score and several OG25 items, could be used to develop or update prognostic models. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

36. Resection of hepatic and pulmonary metastasis from metastatic esophageal and gastric cancer : a nationwide study

Author

Seesing, M F J, van der Veen, A, Brenkman, H J F, Stockmann, H B A C, Nieuwenhuijzen, G A P, Rosman, C, van den Wildenberg, F J H, van Berge Henegouwen, Mark I, van Duijvendijk, P, Wijnhoven, B P L, Stoot, J H M B, Lacle, M, Ruurda, J P, van Hillegersberg, R, Baas, P C, Boerma, D, de Steur, W O, de Waard, J W D, Heisterkamp, J, van Hillo, M, Kouwenhoven, E A, Liem, M S L, van der Peet, D L, Pierie, J P E N, Plukker, J T M, Roumen, R M H, Tetteroo, G W M, van Workum, F, Seesing, M F J, van der Veen, A, Brenkman, H J F, Stockmann, H B A C, Nieuwenhuijzen, G A P, Rosman, C, van den Wildenberg, F J H, van Berge Henegouwen, Mark I, van Duijvendijk, P, Wijnhoven, B P L, Stoot, J H M B, Lacle, M, Ruurda, J P, van Hillegersberg, R, Baas, P C, Boerma, D, de Steur, W O, de Waard, J W D, Heisterkamp, J, van Hillo, M, Kouwenhoven, E A, Liem, M S L, van der Peet, D L, Pierie, J P E N, Plukker, J T M, Roumen, R M H, Tetteroo, G W M, and van Workum, F

Published
2019

37. Resection of hepatic and pulmonary metastasis from metastatic esophageal and gastric cancer: a nationwide study

Author

MS CGO, Cancer, Heelkunde Opleiding, Pathologie Pathologen staf, Divisie Beeld & Oncologie, Seesing, M F J, van der Veen, A, Brenkman, H J F, Stockmann, H B A C, Nieuwenhuijzen, G A P, Rosman, C, van den Wildenberg, F J H, van Berge Henegouwen, Mark I, van Duijvendijk, P, Wijnhoven, B P L, Stoot, J H M B, Lacle, M, Ruurda, J P, van Hillegersberg, R, Baas, P C, Boerma, D, de Steur, W O, de Waard, J W D, Heisterkamp, J, van Hillo, M, Kouwenhoven, E A, Liem, M S L, van der Peet, D L, Pierie, J P E N, Plukker, J T M, Roumen, R M H, Tetteroo, G W M, van Workum, F, MS CGO, Cancer, Heelkunde Opleiding, Pathologie Pathologen staf, Divisie Beeld & Oncologie, Seesing, M F J, van der Veen, A, Brenkman, H J F, Stockmann, H B A C, Nieuwenhuijzen, G A P, Rosman, C, van den Wildenberg, F J H, van Berge Henegouwen, Mark I, van Duijvendijk, P, Wijnhoven, B P L, Stoot, J H M B, Lacle, M, Ruurda, J P, van Hillegersberg, R, Baas, P C, Boerma, D, de Steur, W O, de Waard, J W D, Heisterkamp, J, van Hillo, M, Kouwenhoven, E A, Liem, M S L, van der Peet, D L, Pierie, J P E N, Plukker, J T M, Roumen, R M H, Tetteroo, G W M, and van Workum, F

Published
2019

43. Evaluation of PET and laparoscopy in STagIng advanced gastric cancer : A multicenter prospective study (PLASTIC-study)

Author

Brenkman, H. J.F., Gertsen, E. C., Vegt, E., van Hillegersberg, R., van Berge Henegouwen, M. I., Gisbertz, S. S., Luyer, M. D.P., Nieuwenhuijzen, G. A.P., van Lanschot, J. J.B., Lagarde, S. M., de Steur, W. O., Hartgrink, H. H., Stoot, J. H.M.B., Hulsewe, K. W.E., Spillenaar Bilgen, E. J., van Det, M. J., Kouwenhoven, E. A., van der Peet, D. L., Daams, F., van Sandick, J. W., van Grieken, N. C.T., Heisterkamp, J., van Etten, B., Haveman, J. W., Pierie, J. P., Jonker, F., Thijssen, A. Y., Belt, E. J.T., van Duijvendijk, P., Wassenaar, E., van Laarhoven, H. W.M., Wessels, F. J., Haj Mohammad, N., van Stel, H. F., Frederix, G. W.J., Siersema, P. D., Ruurda, J. P., on behalf of the PLASTIC Study Group, Brenkman, H. J.F., Gertsen, E. C., Vegt, E., van Hillegersberg, R., van Berge Henegouwen, M. I., Gisbertz, S. S., Luyer, M. D.P., Nieuwenhuijzen, G. A.P., van Lanschot, J. J.B., Lagarde, S. M., de Steur, W. O., Hartgrink, H. H., Stoot, J. H.M.B., Hulsewe, K. W.E., Spillenaar Bilgen, E. J., van Det, M. J., Kouwenhoven, E. A., van der Peet, D. L., Daams, F., van Sandick, J. W., van Grieken, N. C.T., Heisterkamp, J., van Etten, B., Haveman, J. W., Pierie, J. P., Jonker, F., Thijssen, A. Y., Belt, E. J.T., van Duijvendijk, P., Wassenaar, E., van Laarhoven, H. W.M., Wessels, F. J., Haj Mohammad, N., van Stel, H. F., Frederix, G. W.J., Siersema, P. D., Ruurda, J. P., and on behalf of the PLASTIC Study Group

Published
2018

44. Multicentre randomized clinical trial of inspiratory muscle training versus usual care before surgery for oesophageal cancer

Author

Valkenet, K., Trappenburg, J. C.A., Ruurda, J. P., Guinan, E. M., Reynolds, J. V., Nafteux, P., Fontaine, M., Rodrigo, H. E., van der Peet, D. L., Hania, S. W., Sosef, M. N., Willms, J., Rosman, C., Pieters, H., Scheepers, J. J.G., Faber, T., Kouwenhoven, E. A., Tinselboer, M., Räsänen, J., Ryynänen, H., Gosselink, R., van Hillegersberg, R., Backx, F. J.G., Valkenet, K., Trappenburg, J. C.A., Ruurda, J. P., Guinan, E. M., Reynolds, J. V., Nafteux, P., Fontaine, M., Rodrigo, H. E., van der Peet, D. L., Hania, S. W., Sosef, M. N., Willms, J., Rosman, C., Pieters, H., Scheepers, J. J.G., Faber, T., Kouwenhoven, E. A., Tinselboer, M., Räsänen, J., Ryynänen, H., Gosselink, R., van Hillegersberg, R., and Backx, F. J.G.

Published
2018

45. Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: A multicenter prospective study (PLASTIC-study)

Author

MS CGO, Cancer, Divisie Beeld & Oncologie, MS Radiologie, MS Medische Oncologie, Verplegingswetenschap, Other research (not in main researchprogram), JC onderzoeksprogramma Methodologie, HEE, Child Health, Brenkman, H. J.F., Gertsen, E. C., Vegt, E., van Hillegersberg, R., van Berge Henegouwen, M. I., Gisbertz, S. S., Luyer, M. D.P., Nieuwenhuijzen, G. A.P., van Lanschot, J. J.B., Lagarde, S. M., de Steur, W. O., Hartgrink, H. H., Stoot, J. H.M.B., Hulsewe, K. W.E., Spillenaar Bilgen, E. J., van Det, M. J., Kouwenhoven, E. A., van der Peet, D. L., Daams, F., van Sandick, J. W., van Grieken, N. C.T., Heisterkamp, J., van Etten, B., Haveman, J. W., Pierie, J. P., Jonker, F., Thijssen, A. Y., Belt, E. J.T., van Duijvendijk, P., Wassenaar, E., van Laarhoven, H. W.M., Wessels, F. J., Haj Mohammad, N., van Stel, H. F., Frederix, G. W.J., Siersema, P. D., Ruurda, J. P., on behalf of the PLASTIC Study Group, MS CGO, Cancer, Divisie Beeld & Oncologie, MS Radiologie, MS Medische Oncologie, Verplegingswetenschap, Other research (not in main researchprogram), JC onderzoeksprogramma Methodologie, HEE, Child Health, Brenkman, H. J.F., Gertsen, E. C., Vegt, E., van Hillegersberg, R., van Berge Henegouwen, M. I., Gisbertz, S. S., Luyer, M. D.P., Nieuwenhuijzen, G. A.P., van Lanschot, J. J.B., Lagarde, S. M., de Steur, W. O., Hartgrink, H. H., Stoot, J. H.M.B., Hulsewe, K. W.E., Spillenaar Bilgen, E. J., van Det, M. J., Kouwenhoven, E. A., van der Peet, D. L., Daams, F., van Sandick, J. W., van Grieken, N. C.T., Heisterkamp, J., van Etten, B., Haveman, J. W., Pierie, J. P., Jonker, F., Thijssen, A. Y., Belt, E. J.T., van Duijvendijk, P., Wassenaar, E., van Laarhoven, H. W.M., Wessels, F. J., Haj Mohammad, N., van Stel, H. F., Frederix, G. W.J., Siersema, P. D., Ruurda, J. P., and on behalf of the PLASTIC Study Group

Published
2018

46. Multicentre randomized clinical trial of inspiratory muscle training versus usual care before surgery for oesophageal cancer

Author

Fysiotherapiewetenschap, RF&S Team 2 Medisch, Verplegingswetenschap, JC onderzoeksprogramma Methodologie, MS CGO, Cancer, HAG Zorg, Perfusie, Divisie Beeld & Oncologie, Brain, Valkenet, K., Trappenburg, J. C.A., Ruurda, J. P., Guinan, E. M., Reynolds, J. V., Nafteux, P., Fontaine, M., Rodrigo, H. E., van der Peet, D. L., Hania, S. W., Sosef, M. N., Willms, J., Rosman, C., Pieters, H., Scheepers, J. J.G., Faber, T., Kouwenhoven, E. A., Tinselboer, M., Räsänen, J., Ryynänen, H., Gosselink, R., van Hillegersberg, R., Backx, F. J.G., Fysiotherapiewetenschap, RF&S Team 2 Medisch, Verplegingswetenschap, JC onderzoeksprogramma Methodologie, MS CGO, Cancer, HAG Zorg, Perfusie, Divisie Beeld & Oncologie, Brain, Valkenet, K., Trappenburg, J. C.A., Ruurda, J. P., Guinan, E. M., Reynolds, J. V., Nafteux, P., Fontaine, M., Rodrigo, H. E., van der Peet, D. L., Hania, S. W., Sosef, M. N., Willms, J., Rosman, C., Pieters, H., Scheepers, J. J.G., Faber, T., Kouwenhoven, E. A., Tinselboer, M., Räsänen, J., Ryynänen, H., Gosselink, R., van Hillegersberg, R., and Backx, F. J.G.

Published
2018

47. Nationwide Outcome of Gastrectomy with En-Bloc Partial Pancreatectomy for Gastric Cancer.

Author

van der Werf, L. R., Eshuis, W. J., Draaisma, W. A., van Etten, B., Gisbertz, S. S., van der Harst, E., Liem, M. S. L., Lemmens, V. E. P. P., Wijnhoven, B. P. L., Besselink, M. G., van Berge Henegouwen, M. I., on behalf of the Dutch Upper Gastrointestinal Cancer Audit (DUCA) group., van Hillegersberg, R., van Eijden, Y., van Esser, S., Hartgrink, H. H., de Jong, G., Karsten, T. M., Kouwenhoven, E. A., and Lagarde, S. M.

Subjects
PANCREATECTOMY, STOMACH cancer, GASTRECTOMY, SURGICAL complications, PANCREATIC tumors, LOGISTIC regression analysis
Abstract

Background: Radical gastrectomy is the cornerstone of the treatment of gastric cancer. For tumors invading the pancreas, en-bloc partial pancreatectomy may be needed for a radical resection. The aim of this study was to evaluate the outcome of gastrectomies with partial pancreatectomy for gastric cancer.Methods: Patients who underwent gastrectomy with or without partial pancreatectomy for gastric or gastro-oesophageal junction cancer between 2011 and 2015 were selected from the Dutch Upper GI Cancer Audit (DUCA). Outcomes were resection margin (pR0) and Clavien-Dindo grade ≥ III postoperative complications and survival. The association between partial pancreatectomy and postoperative complications was analyzed with multivariable logistic regression. Overall survival of patients with partial pancreatectomy was estimated using the Kaplan-Meier method.Results: Of 1966 patients that underwent gastrectomy, 55 patients (2.8%) underwent en-bloc partial pancreatectomy. A pR0 resection was achieved in 45 of 55 patients (82% versus 85% in the group without additional resection, P = 0.82). Clavien-Dindo grade ≥ III complications occurred in 21 of 55 patients (38% versus 17%, P < 0.001). Median overall survival [95% confidence interval] was 15 [6.8-23.2] months. For patients with and without perioperative systemic therapy, median survival was 20 [12.3-27.7] and 10 [5.7-14.3] months, and for patients with pR0 and pR1 resection, it was 20 [11.8-28.3] and 5 [2.4-7.6] months, respectively.Conclusions: Gastrectomy with partial pancreatectomy is not only associated with a pR0 resection rate of 82% but also with increased postoperative morbidity. It should only be performed if a pR0 resection is feasible. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

48. Multicentre randomized clinical trial of inspiratory muscle training versus usual care before surgery for oesophageal cancer

Author

Valkenet, K, primary, Trappenburg, J C A, additional, Ruurda, J P, additional, Guinan, E M, additional, Reynolds, J V, additional, Nafteux, P, additional, Fontaine, M, additional, Rodrigo, H E, additional, van der Peet, D L, additional, Hania, S W, additional, Sosef, M N, additional, Willms, J, additional, Rosman, C, additional, Pieters, H, additional, Scheepers, J J G, additional, Faber, T, additional, Kouwenhoven, E A, additional, Tinselboer, M, additional, Räsänen, J, additional, Ryynänen, H, additional, Gosselink, R, additional, van Hillegersberg, R, additional, and Backx, F J G, additional

Published
2018
Full Text
View/download PDF

49. Factors contributing to variation in the use of multimodality treatment in patients with gastric cancer: A Dutch population based study

Author

Beck, N., primary, Busweiler, L.A.D., additional, Schouwenburg, M.G., additional, Fiocco, M., additional, Cats, A., additional, Voncken, F.E.M., additional, Wijnhoven, B.P.L., additional, van Berge Henegouwen, M.I., additional, Wouters, M.W.J.M., additional, van Sandick, J.W., additional, Bosscha, K., additional, Dikken, J.L., additional, van Duijvendijk, P., additional, van Grieken, N.C.T., additional, Gisbertz, S.S., additional, Hartgrink, H.H., additional, Hartemink, K.J., additional, Van Hillegersberg, R., additional, Hulsewé, K., additional, Kouwenhoven, E., additional, Lemmens, V.E.P.P., additional, Nieuwenhuijzen, G.A.P., additional, Ooijen, B., additional, Plukker, J.T., additional, Rosman, C., additional, Scheepers, J., additional, Siersema, P.D., additional, de Steur, W.O., additional, Tetteroo, G., additional, and Veldhuis, P.M.J.F., additional

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results